Drugs / Bisnorcymserine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01747213 | Jan 2013 → Sep 2018 | — | National Institute on Aging (NIA) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bisnorcymserine | “Scientists at the NIA/NIH have developed a novel BChE inhibitor called Bisnorcymserine (BNC).” NCT01747213 ↗ |
| Known as | BNC | “Scientists at the NIA/NIH have developed a novel BChE inhibitor called Bisnorcymserine (BNC).” NCT01747213 ↗ |
| Action | Inhibit | “a highly selective inhibitor of Butyrylcholinesterase” NCT01747213 ↗ |